Vosoritide potentially life-saving for children with common form of dwarfism 

Casper has achondroplasia, and has benefited from a new therapy involving the bone growth drug Vosoritide. This trial has been led by Professor Ravi Savarirayan at the Murdoch Children's Research Institute, with the treatment approved from birth in Australia.